Handelsbanken Fonder’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Sell |
|
|||||
|
2025
Q1 | $4.07M | Buy |
|
|||||
|
2024
Q4 | $3.21M | Sell |
|
|||||
|
2024
Q3 | $8.72M | Buy |
|
|||||
|
2024
Q2 | $10M | Buy |
|
|||||
|
2024
Q1 | $8.46M | Buy |
|
|||||
|
2023
Q4 | $8.68M | Sell |
|
|||||
|
2023
Q3 | $8.12M | Buy |
|
|||||
|
2023
Q2 | $7.82M | Buy |
|
|||||
|
2023
Q1 | $7.56M | Buy |
|
|||||
|
2022
Q4 | $7.79M | Buy |
|
|||||
|
2022
Q3 | $5.96M | Hold |
|
|||||
|
2022
Q2 | $5.82M | Sell |
|
|||||
|
2022
Q1 | $23.3M | Sell |
|
|||||
|
2021
Q4 | $27.1M | Buy |
|
|||||
|
2021
Q3 | $17.1M | Buy |
|
|||||
|
2021
Q2 | $18.1M | Buy |
|
|||||
|
2021
Q1 | $3.23M | Sell |
|
|||||
|
2020
Q4 | $3.79M | Sell |
|
|||||
|
2020
Q3 | $3.29M | Buy |
|
|||||
|
2020
Q2 | $5.14M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.53M | Hold |
|
|||||
|
2016
Q2 | $1.28M | Sell |
|
|||||
|
2016
Q1 | $1.77M | Sell |
|
|||||
|
2015
Q4 | $4.14M | Buy |
|